Skip to main content
Top
Published in: International Cancer Conference Journal 2/2018

01-04-2018 | Case report

A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma

Authors: Shingo Toyama, Yoshiyuki Shioyama, Hiroaki Suefuji, Makoto Shinoto, Keiji Matsumoto, Kotaro Terashima, Masaaki Hidaka, Susumu Eguchi, Kuniko Abe, Hiroyuki Irie, Yuichiro Eguchi

Published in: International Cancer Conference Journal | Issue 2/2018

Login to get access

Abstract

The patient was a 50-year-old female with an initial diagnosis of a single hepatocellular carcinoma in liver cirrhosis. The tumor was located in the posterior liver segment (S7) and measured 5 cm with a rapid growth rate and portal invasion. The pre-treatment Child-Pugh (C-P) was grade A (six points). The total prescribed dose of carbon-ion radiotherapy (C-ion RT) was 60 Gy (relative biological effectiveness) given in 4 fractions. Thereafter, tumor shrinkage and rapid decrease of the serum alpha-fetoprotein level were observed. At 1-year follow-up a new lesion was diagnosed in the left lobe and the underlying liver failure had worsened to C-P grade B (eight points). Thus, she was recommended to undergo living-donor liver transplantation (LDLT). The postoperative course was uneventful. At pathological examination, no viable tumor cells in the region treated with C-ion RT were detected. At the time of the last follow-up, the patient was in overall good general condition with no signs of tumor recurrence.
Literature
1.
go back to reference Schlachterman A, Craft WW Jr, Hilgenfeldt E et al (2015) Current and future treatments for hepatocellular carcinoma. World J Gastroenterol 21:8478–8491CrossRefPubMedPubMedCentral Schlachterman A, Craft WW Jr, Hilgenfeldt E et al (2015) Current and future treatments for hepatocellular carcinoma. World J Gastroenterol 21:8478–8491CrossRefPubMedPubMedCentral
3.
go back to reference Kalogeridi MA, Zygogianni A, Kyrgias G et al (2015) Role of radiotherapy in the management of hepatocellular carcinoma: a systematic review. World J Hepatol 27:101–112CrossRef Kalogeridi MA, Zygogianni A, Kyrgias G et al (2015) Role of radiotherapy in the management of hepatocellular carcinoma: a systematic review. World J Hepatol 27:101–112CrossRef
4.
go back to reference Abe T, Saitoh J, Kobayashi D et al (2015) Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma. Radiat Oncol 10:187CrossRefPubMedPubMedCentral Abe T, Saitoh J, Kobayashi D et al (2015) Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma. Radiat Oncol 10:187CrossRefPubMedPubMedCentral
5.
go back to reference Kato H, Tsujii H, Miyamoto T et al (2004) Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59:1468–1476CrossRefPubMed Kato H, Tsujii H, Miyamoto T et al (2004) Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59:1468–1476CrossRefPubMed
6.
go back to reference Imada H, Kato H, Yasuda S et al (2010) Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol 96:231–235CrossRefPubMed Imada H, Kato H, Yasuda S et al (2010) Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol 96:231–235CrossRefPubMed
7.
go back to reference Abe T, Shibuya K, Koyama Y et al (2016) Initial results of hypofractionated carbon ion radiotherapy for cholangiocarcinoma. Anticancer Res 36:2955–2960CrossRefPubMed Abe T, Shibuya K, Koyama Y et al (2016) Initial results of hypofractionated carbon ion radiotherapy for cholangiocarcinoma. Anticancer Res 36:2955–2960CrossRefPubMed
Metadata
Title
A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma
Authors
Shingo Toyama
Yoshiyuki Shioyama
Hiroaki Suefuji
Makoto Shinoto
Keiji Matsumoto
Kotaro Terashima
Masaaki Hidaka
Susumu Eguchi
Kuniko Abe
Hiroyuki Irie
Yuichiro Eguchi
Publication date
01-04-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 2/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0322-5

Other articles of this Issue 2/2018

International Cancer Conference Journal 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine